Proteomic fingerprinting was able to distinguish pSS from non-pSS controls with a sensitivity of 77.1 % and a specificity of 85.5 %, and was effective in the diagnosis of pSS. PubMed, Clin Rheumatol, 2014 Sep 2. (Also see: Diagnosis of Sjogren's Syndrome)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.